abstract |
The present invention relates to the novel quinazolin-4-one derivatives of formula I, as described in the specification, to pharmaceutical compositions containing said compounds, to the use of said compounds to treat disorders of the central nervous system and peripheral neurodegenerative, psychotropic, and alcohol and drug induced. |